87 results on '"Garcia Pinilla, Jose Manuel"'
Search Results
2. Repetitive ambulatory levosimendan as a bridge to heart transplantation
3. Levosimendán ambulatorio repetitivo como puente al trasplante cardiaco
4. Prevalencia de amiloidosis cardiaca por transtirretina en pacientes con insuficiencia cardiaca y fracción de eyección conservada: estudio PRACTICA
5. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study
6. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry
7. Prevalencia y perfil clínico de la enfermedad renal en pacientes con insuficiencia cardiaca crónica. Datos del Registro cardiorrenal español
8. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status
9. La reducción temprana del filtrado glomerular se asocia con aumento de la hemoglobina tras el inicio de dapagliflozina en la insuficiencia cardiaca con fracción de eyección reducida
10. Abstract 18395: Urinary Metals as Novel Risk Factors for Incident Heart Failure and Subtypes in Indigenous Communities in the US: Evidence From the Strong Heart Study
11. Caracterización de la amiloidosis cardiaca hereditaria por transtirretina en España
12. Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study.
13. Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations
14. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
15. Selección de lo mejor del año 2020 en insuficiencia cardiaca
16. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
17. La consulta telemática para el cardiólogo clínico en tiempos de la COVID-19: presente y futuro. Documento de consenso de la Sociedad Española de Cardiología
18. Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term
19. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study
20. Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia cardiaca, trasplante cardiaco y asistencia ventricular. Recomendaciones de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología
21. Selección de lo mejor del año 2019 en insuficiencia cardiaca
22. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry
23. Selección de lo mejor del año 2018 en insuficiencia cardiaca
24. Usefulness of Genetic Study by Next-generation Sequencing in High-risk Arrhythmogenic Cardiomyopathy
25. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status
26. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy
27. Genetic Etiology for Alcohol-Induced Cardiac Toxicity
28. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
29. Causes of death in atrial fibrillation: Challenges and opportunities
30. Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms
31. Clinical Cardiology, Geriatric Cardiology, Heart Failure, and Transplantation 2015: A Selection of Topical Issues
32. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy
33. Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
34. Abstract P592: Risk Factors for Heart Failure Subtypes in a Population With a High Burden of Diabetes- Evidence From the Strong Heart Study
35. Case Report: COVID-19 with cytokine storm in a 16-year-old patient: if heart failures comes think about levosimendan
36. Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry
37. Update for 2014 on Clinical Cardiology, Geriatric Cardiology, and Heart Failure and Transplantation
38. Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction
39. 2013 Update on Congenital Heart Disease, Clinical Cardiology, Heart Failure, and Heart Transplant
40. Short-Term Changes in Peak VO2After Initiation of Dapagliflozin in Heart Failure Across Iron Status
41. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
42. Determinación de valores de impedancia periférica en pacientes ingresados por insuficiencia cardiaca
43. Homocisteína y cardiopatía isquémica: ¿marcador pronóstico o diana terapéutica?
44. Coronary Disease Extension Determines Mobilization of Endothelial Progenitor Cells and Cytokines After a First Myocardial Infarction With ST Elevation
45. Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial.
46. Case Report: COVID-19 with cytokine storm in a 16-year-old patient: if heart failures comes think about levosimendan
47. Influence of high homocysteine and low folate plasmatic levels in medium-term prognosis after acute coronary syndromes
48. Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise
49. Analysis of the activity of the telephone nursing consultation on demand for patients with heart failure
50. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.